Sign In
Buy CGEN
$2.19
-0.0700 (-3.10%)
At Close: Jun 03, 2026
HOLON, Israel, May 10, 2021 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that it has expa
Compugen to Release First Quarter 2021 Results on Thursday, May 13, 2021
07:00am, Monday, 03'rd May 2021
HOLON, Israel, May 3, 2021 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, announced today that the Company wi
Compugen to Present Data Update on COM701 Phase 1 Clinical Trial at the American Society of Clinical Oncology 2021 Annual Meeting
07:00am, Thursday, 29'th Apr 2021
HOLON, Israel, April 29, 2021 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that it will pr
Compugen Publishes Preclinical Data Demonstrating Therapeutic Potential of COM902 in Cancer Immunology, Immunotherapy
07:00am, Tuesday, 27'th Apr 2021
HOLON, Israel, April 27, 2021 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced the publication
7 Stocks That Could Double by Summer
02:29pm, Monday, 05'th Apr 2021
These seven stocks may be risky, but they also have the potential for big returns -- as all of them are stocks that could double by summer. The post 7 Stocks That Could Double by Summer appeared first
ARK Invest: Illiquid Positions Threaten to Drown Bubbly ETFs
02:24pm, Thursday, 04'th Mar 2021
Catherine Wood has plunged deeper into illiquid stocks in an effort to prop up faltering positions
Compugen: Serious Partnerships, Tremendous Potential, But Several Years To Wait
06:55am, Sunday, 28'th Feb 2021
Compugen is an early-stage biotechnology company developing cancer immunotherapies from predictive computational discovery platforms. Compugen has an early-stage pipeline of three computationally-disc
ARK Invest: Danger Looms as High-Flying ETFs Falter
11:06am, Friday, 26'th Feb 2021
ARK Investment Management – or ARK Invest, as it usually styles itself – had a great 2020. ARK Innovation ETF (ARKK), the firm's flagship fund, returned more than 150% last year.
Compugen Ltd. (CGEN) CEO Anat Cohen-Dayag on Q4 2020 Results - Earnings Call Transcript
05:50pm, Thursday, 25'th Feb 2021
Compugen Ltd. (CGEN) CEO Anat Cohen-Dayag on Q4 2020 Results - Earnings Call Transcript
Compugen Reports Fourth Quarter and Full Year 2020 Results
07:05am, Thursday, 25'th Feb 2021
HOLON, Israel, Feb. 25, 2021 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today reported financial results f
Compugen To Test COM701, Opdivo Combination In Solid Tumor Settings
01:58pm, Monday, 22'nd Feb 2021
Compugen Ltd (NASDAQ: CGEN) expands its clinical collaboration agreement with Bristol-Myers Squibb Co (NYSE: BMY), wherein Bristol Myers will supply Opdivo (nivolumab) for Compugen's Phase 1b c
HOLON, Israel, Dec. 23, 2020 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, announced today progress from its
Compugen Ltd. (CGEN) CEO Anat Cohen-Dayag on Q3 2020 Results - Earnings Call Transcript
09:01pm, Friday, 06'th Nov 2020
Compugen Ltd. (CGEN) CEO Anat Cohen-Dayag on Q3 2020 Results - Earnings Call Transcript
Evogene: Hidden Gems Of Computational Predictive Biology (Part 3 Of 4) - Ag Plenus (Novel Herbicides And Pesticides)
10:48am, Wednesday, 02'nd Sep 2020
Evogene's 100% owned subsidiary AgPlenus utilizes Evogene's computational predictive biology platform to develop Ag-Chemicals (novel herbicides, insecticides and other crop control products).
3 Important Things I've Learned Reviewing ARK's ETFs
10:53am, Monday, 24'th Aug 2020
ARK Invest currently offers some of the best performing ETFs over the past five years. The five actively managed ETFs provided by ARK cover innovation, autonomous technology and robotics, next generat
